Skip to main content
Clinical Trials/ACTRN12622001270707
ACTRN12622001270707
Not yet recruiting
未知

Optimising Adherence Pilot Program: Investigating the impact of a novel intervention on the incidence of trismus during radiotherapy for head and neck cancer patients

Chris O'Brien Lifehouse0 sites30 target enrollmentSeptember 26, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Chris O'Brien Lifehouse
Enrollment
30
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 26, 2022
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 18 years and older
  • Diagnosis of head and neck cancer (HNC)
  • Planned for radiotherapy to treat HNC
  • Willingness to give informed consent

Exclusion Criteria

  • Patients where trismus therapy is contraindicated due to medical/surgical parameters, guided by their managing physician.

Outcomes

Primary Outcomes

Not specified

Similar Trials